Close Menu

depression

AssureRx has added a fifth gene, CYP1A2, to its GeneSightRx pharmacogenomic test to guide treatment decisions for psychiatric patients.

WSU and the Michigan Technology and Research Institute are seeking funding to form a company to shepherd to clinical trials WSU's first candidate, a triple uptake inhibitor for treating depression. They eventually hope to attract a pharma partner for further development.

The toolkit is the first product released under the Consensus Measures for Phenotypes and eXposures initiative, which is a three-year project aimed at developing a set of standard measures across 20 research categories related to health and common diseases.

The approximately $17 million acquisition, announced last week, will have "no impact" on Clinical Data's focus as a pharmacogenomics company, according to CEO Drew Fromkin.

Clinical Data will use the funds to support late-stage development of two of its drugs.

New Products: Feb 6, 2009

Premium

Aruna Biomedical

Snippets: Feb 4, 2009

Premium

National Institutes of Health, Genomic Health, Decode Genetics, Myriad Genetics, Exact Sciences, and more …

Pages

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.